ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

24,652Medicare Part D Prescriptions Filled, Including Refills

Rank: 46 out of 1456

$1.34M Total Retail Price of All Prescriptions

Rank: 51 out of 1456

546 Patients Receiving at Least One Drug in Part D
75%Patients 65 Years and Older
72% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Georgia
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 546 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

27% of this provider’s 546 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

2% of this provider’s 19,035 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$54 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

45 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Georgia
LEVOTHYROXINE SODIUM 1,053 840 1 4
LISINOPRIL 875 650 2 3
AMLODIPINE BESYLATE 872 718 3 1
OMEPRAZOLE 663 478 4 5
FUROSEMIDE 598 473 5 7
HYDROCODONE-ACETAMINOPHEN 553 412 S3 6 6
PRAVASTATIN SODIUM 517 404 7 9
SIMVASTATIN 469 345 8 2
WARFARIN SODIUM 467 428 9 21
DONEPEZIL HCL 448 406 10 29
METFORMIN HCL 447 311 11 8
METOPROLOL TARTRATE 426 338 12 12
ATORVASTATIN CALCIUM 399 313 13 11
RANITIDINE HCL 357 279 14 27
CARVEDILOL 333 289 15 20
NAMENDA 325 272 16 38
NEXIUM 310 216 17 23
SERTRALINE HCL 284 207 18 25
HYDROCHLOROTHIAZIDE 275 208 19 10
POTASSIUM CHLORIDE 266 203 20 15
ALENDRONATE SODIUM 261 235 21 36
TAMSULOSIN HCL 254 206 22 34
LOVASTATIN 249 218 23 40
GABAPENTIN 236 160 24 13
METOPROLOL SUCCINATE 233 196 25 19
QUETIAPINE FUMARATE 232 173 26 78
DIVALPROEX SODIUM 231 196 27 108
LOSARTAN POTASSIUM 211 195 28 16
LISINOPRIL-HYDROCHLOROTHIAZIDE 207 141 29 24
ZETIA 207 178 29 71
TRAZODONE HCL 201 137 31 47
AZITHROMYCIN 196 150 32 44
CLOPIDOGREL 190 156 33 32
RISPERIDONE 187 137 34 72
PREDNISONE 185 159 35 42
ZOLPIDEM TARTRATE 174 128 36 14
HYDRALAZINE HCL 168 118 37 48
FLUTICASONE PROPIONATE 168 114 37 28
SULFAMETHOXAZOLE-TRIMETHOPRIM 154 129 39 107
CITALOPRAM HBR 147 105 40 22
KLOR-CON 10 145 120 41 96
BUSPIRONE HCL 143 85 42 151
TRAMADOL HCL 141 88 43 17
ATENOLOL 139 113 44 18
LANTUS 137 92 45 50
ESCITALOPRAM OXALATE 136 110 46 74
CLONIDINE HCL 130 114 47 39
MELOXICAM 129 61 48 30
SINGULAIR 127 99 49 83
ADVAIR DISKUS 127 95 49 63
PANTOPRAZOLE SODIUM 122 84 51 43
PLAVIX 120 98 52 46
DIOVAN 117 78 53 35
CYCLOBENZAPRINE HCL 112 79 R 54 66
ALLOPURINOL 111 99 55 31
DIGOXIN 108 100 56 62
ALBUTEROL SULFATE 105 90 57 136
ROPINIROLE HCL 105 87 57 90
DIVALPROEX SODIUM ER 105 56 57 227
LIPITOR 104 77 60 76
FENOFIBRATE 101 70 61 56
KLOR-CON M20 100 71 62 51
VERAPAMIL ER 99 88 63 82
ACTOS 97 84 64 115
CARBIDOPA-LEVODOPA 96 78 65 141
MIRTAZAPINE 96 80 65 65
LACTULOSE 95 46 67 192
FINASTERIDE 95 71 67 110
ABILIFY 93 81 69 244
FENTANYL 93 92 S2 69 114
VENLAFAXINE HCL ER 88 82 71 89
DICLOFENAC SODIUM 88 59 71 95
CLOTRIMAZOLE-BETAMETHASONE 86 54 73 163
JANUVIA 86 66 73 68
LOSARTAN-HYDROCHLOROTHIAZIDE 85 76 75 41
LEVETIRACETAM 83 57 76 97
SPIRIVA 82 71 77 75
OXYCODONE-ACETAMINOPHEN 81 75 S2 78 109
SPIRONOLACTONE 81 66 78 73
DILTIAZEM 24HR ER 79 66 80 126
LEVOFLOXACIN 77 56 81 79
GLIPIZIDE 73 58 82 53
LYRICA 73 65 82 91
CRESTOR 72 70 84 26
TRILIPIX 71 61 85 188
KLOR-CON M10 71 48 85 140
OLANZAPINE 70 20 87 183
SEROQUEL 69 59 88 154
DICYCLOMINE HCL 68 48 89 239
MONTELUKAST SODIUM 67 47 90 135
PHENYTOIN SODIUM EXTENDED 67 62 90 128
VESICARE 67 44 90 200
GLYBURIDE 66 65 R 93 94
GLIPIZIDE XL 65 65 94 134
POLYETHYLENE GLYCOL 3350 64 48 95 85
NIASPAN 62 51 96 127
MEGESTROL ACETATE 61 60 R 97 179
PROAIR HFA 61 35 97 69
PROMETHAZINE HCL 61 51 R 97 77
LANTUS SOLOSTAR 61 40 97 120
DOXYCYCLINE HYCLATE 60 36 101 129
FLUOXETINE HCL 60 17 101 55
TRIAMTERENE-HCTZ 60 51 101 49
DEXILANT 59 44 104 169
GLIMEPIRIDE 57 40 105 33
PIOGLITAZONE HCL 56 48 R 106 279
NOVOLIN 70-30 56 42 106 144
AMOX TR-POTASSIUM CLAVULANATE 55 37 108 118
HUMULIN 70-30 54 34 109 205
BUPROPION XL 54 42 109 165
TERAZOSIN HCL 53 37 111 142
TRICOR 52 46 112 92
ENALAPRIL MALEATE 52 49 112 87
PHENYTOIN 52 35 112 253
IBUPROFEN 51 25 115 103
BENZTROPINE MESYLATE 50 0 R 116 222
VALPROIC ACID 50 45 116 230
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 3, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.